Sound-Wave TTTS Treatment Saves 12 of 20 Twin Babies in World-First Trial
Updated
Updated · BBC.com · Jul 10
Sound-Wave TTTS Treatment Saves 12 of 20 Twin Babies in World-First Trial
3 articles · Updated · BBC.com · Jul 10
Summary
A 10-woman trial found a non-invasive high-powered ultrasound procedure saved 12 of 20 babies with twin-to-twin transfusion syndrome, with no unwanted side-effects reported.
The treatment seals placental blood vessels causing the imbalance without inserting a needle or telescope into the womb, blocking blood flow in 90% of targeted vessels in about 20 minutes.
Half the women still needed further treatment, underscoring researchers' warning that larger studies are required before the procedure can be offered widely.
Brioney Garrett's twins, Nancy and Margo, were the first treated and were born healthy at nearly 34 weeks; now aged four, they are due to start primary school.
TTTS affects 10% to 15% of identical twins sharing a placenta—about 300 to 400 UK pregnancies a year—and current treatment usually requires invasive laser surgery or fluid drainage.
Why did this 'miracle' ultrasound for twins still require invasive surgery for half the mothers in the trial?
If sound waves can now perform surgery in the womb, what other fetal conditions could this technology treat next?
Non-Invasive HIFU Achieves 90% Vessel Blockage in First Human Trial for Twin-to-Twin Transfusion Syndrome: A Safer Future for Fetal Therapy?
Overview
A major breakthrough in fetal medicine has been achieved with the first clinical trial of High-Intensity Focused Ultrasound (HIFU) as a non-invasive treatment for Twin-to-Twin Transfusion Syndrome (TTTS). Conducted at leading UK hospitals and universities, this Phase 1a trial enrolled women with early TTTS and used HIFU to precisely target and block abnormal placental blood vessels, all without surgery or instruments entering the womb. The study marks a potential turning point in TTTS care, showing that HIFU is technically feasible and safe, and could offer a safer alternative to current invasive treatments in the future.